Discover 443 paid clinical trials in Tucson, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With major studies in this city focused on conditions like Alzheimer's disease, lymphoma, asthma, and various forms of cancer, Tucson offers participants access to innovative care and breakthrough treatments. The city’s strong research network provides opportunities for individuals seeking to explore new treatment options while making a positive impact on medical research and advancements in healthcare.
Filter
2
Filter results
Results: 443
New
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
for
Influenza, Human
Location: Tucson AZ, Mesa AZ, Tempe AZ, Scottsdale AZ,
Sponsor: GlaxoSmithKline
Sex: All
Age: 65+
Code: NCT07805707
Phase 3, Recruiting
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
for
Non-alcoholic Fatty Liver Disease
Location: Tucson AZ, Chandler AZ, Las Vegas NV, San Diego CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07221227
Phase 3, Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
for
Liver Diseases, Alcoholic
Location: Tucson AZ, Chandler AZ, Phoenix AZ, Las Vegas NV,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70
Code: NCT06613698
Phase 2, Recruiting
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
for
Metabolic Dysfunction-Associated Steatohepatitis,
Location: Tucson AZ, Chandler AZ, Mesa AZ, Rialto CA, Pasadena CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT06920043
Phase 2, Recruiting
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
for
Mitral Annular Calcification, Mitral Stenosis,
Location: Tucson AZ, Gilbert AZ, Phoenix AZ, Los Angeles CA,
Sponsor: Mayra Guerrero
Sex: All
Age: 18+
Code: NCT04408430
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
for
SLE, SLE (Systemic Lupus)
Location: Tucson AZ, Avondale AZ, Salt Lake City UT, Plano TX,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT06613360
Phase 1, Recruiting
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)